My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ropivacaine Readyfusor 10 mg/h solution for infusion in administration system



BioQ Pharma B.V.PA2284/001/001

Main Information

Trade NameRopivacaine Readyfusor 10 mg/h solution for infusion in administration system
Active SubstancesRopivacaine hydrochloride monohydrate
Dosage FormSolution for infusion in administration system
Licence HolderBioQ Pharma B.V.
Licence NumberPA2284/001/001

Group Information

ATC CodeN01BB Amides
N01BB09 ropivacaine

Status

License statusAuthorised
Licence Issued18/05/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print